{"id":118604,"date":"2021-01-16T16:23:10","date_gmt":"2021-01-17T00:23:10","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2021\/01\/tame-biomarker-qa-with-nir-barzilai-institute-for-aging-research"},"modified":"2021-01-16T16:23:10","modified_gmt":"2021-01-17T00:23:10","slug":"tame-biomarker-qa-with-nir-barzilai-institute-for-aging-research","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2021\/01\/tame-biomarker-qa-with-nir-barzilai-institute-for-aging-research","title":{"rendered":"TAME &amp; Biomarker Q&amp;A with Nir Barzilai, Institute for Aging Research"},"content":{"rendered":"<p><\/p>\n<p><iframe style=\"display: block; margin: 0 auto; width: 100%; aspect-ratio: 4\/3; object-fit: contain;\" src=\"https:\/\/www.youtube.com\/embed\/VFVd_J3CFI4?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; encrypted-media; gyroscope;\n   picture-in-picture\" allowfullscreen><\/iframe><\/p>\n<p>Important here is at 38:13 where he says not only is his TAME trial paid for but an organization is going to pay a billion dollars per year on aging. He was not allowed to give details but it was going to start this month. I\u2019ll be watching for the news.<\/p>\n<hr>\n<p>Zoom Transcription: <a href=\"https:\/\/otter.ai\/u\/vTb6HEbcyTXBPgVrgRzB3I0CDC8\">https:\/\/otter.ai\/u\/vTb6HEbcyTXBPgVrgRzB3I0CDC8<\/a><\/p>\n<p>Dr. Nir Barzilai discusses the TAME Trial and what this group may learn from the successes for advancing progress on biomarkers in particular and on aging in general.<\/p>\n<p>About Nir Barzilai:<\/p>\n<p>Nir Barzilai, MD, is a Professor in the Department of Endocrinology Medicine and the Department of Genetics at the Albert Einstein College of Medicine. He is also the Ingeborg and Ira Leon Rennert Chair of Aging Research at the Albert Einstein College of Medicine.<\/p>\n<div class=\"more-link-wrapper\"> <a class=\"more-link\" href=\"https:\/\/lifeboat.com\/blog\/2021\/01\/tame-biomarker-qa-with-nir-barzilai-institute-for-aging-research\">Continue reading \u201cTAME &amp; Biomarker Q&amp;A with Nir Barzilai, Institute for Aging Research\u201d | &gt;<\/a><\/div><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Important here is at 38:13 where he says not only is his TAME trial paid for but an organization is going to pay a billion dollars per year on aging. He was not allowed to give details but it was going to start this month. I\u2019ll be watching for the news. Zoom Transcription: https:\/\/otter.ai\/u\/vTb6HEbcyTXBPgVrgRzB3I0CDC8 Dr. [\u2026]<\/p>\n","protected":false},"author":388,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,412,269],"tags":[],"class_list":["post-118604","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-genetics","category-life-extension"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/118604","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/388"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=118604"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/118604\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=118604"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=118604"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=118604"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}